2[1]Amoroso A, Del-Porto F, Di MC, et al. Vascular endothelial growth factor: a key mediator of neoangiogenesis[J]. Eur Rev Med Pharmacol Sci, 1997, 1(1-3): 17-25.
3[4]Harris AL. Anti-angiogenesis therapy and strategies for integrating it with adjuvant therapy[J]. Recent Results Cancer Res, 1998,152:341-352.
4[5]Ferrara N , Davis-Smyth T. The biology of vascular enclothelial growth factor[J]. Endccr Rev, 1997, 18(1): 4-25.
5[6]Iruela-Arispe ML, Dvorak HF. Angiogenesis: a dynamic balance of stimulators and inhibitors[J]. Thromb Haemost, 1997, 78(1): 672-677.
6[8]Park J, Keller GA, Fearara N. The vascular endothelial growth factor (VEGF) isoforms: differenctial deposition into the subepithelial extracellular matrix and bioactivity of extracellular matrix-bound VEGF[J].Mol Biol Cell, 1993, 4(12): 1317-1326.
7[9]Brown LF, Detmar M, Claffey K, et al. Vascular permeability factor/vascular endothelial growth factor: a multifunctional angiogenic cytokine[J]. EXS, 1997,79:233-269.
8[10]Yeo KT, Wang HH, Nagy TA, et al. Vasuclar permeability factor (vascular endothelial growth factor) in guinea pig and human tumor and inflammatory effusions[J]. Cancer Res, 1993, 53(12): 2912-2918.
9[11]Kondo S, AsanoM, MatsuoK, etal. Vasculareedothelial growth factor/vascular permeability factor is detectable in the sera of tumor-bearing mice and cancer patients[J]. Bicchim Biophys Acta, 1994, 1221(2): 211-214
10[13]Schlaeppi JM, Eppeberger M, Marting BG, et al. Chemiluminescence immunoassay for vascular endothelial growth factor(vascular permeability factor) in tumor-tissue homogenate[J]. Clin Chem, 1996, 42(11):1777-1784.
